Andrew A. Nierenberg, MD

Original Research

Partial Response, Nonresponse, and Relapse With Selective Serotonin Reuptake Inhibitors in Major Depression: A Survey of Current "Next-Step" Practices

November 30, 2000

Steffany J. Fredman, Maurizio Fava, Allison S. Kienke, et al

Original Research

Efficacy of Fluvoxamine in the Treatment of Major Depression With Comorbid Anxiety Disorders

September 30, 1999

Shamsah B. Sonawalla, Maya K. Spillmann, Andrea R. Kolsky, et al

Article

Evolution of Remission as the New Standard in the Treatment of Depression

August 1, 1999

Andrew A. Nierenberg, Emma C. Wright

Article

Evolution of Remission as the New Standard in the Treatment of Depression

August 1, 1999

Andrew A. Nierenberg, Emma C. Wright

Original Research

Residual Symptoms in Depressed Patients Who Respond Acutely to Fluoxetine

April 30, 1999

Andrew A. Nierenberg, Bronwyn R. Keefe, Vinita C. Leslie, et al

Original Research

The Texas Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder

March 31, 1999

M. Lynn Crismon, Madhukar Trivedi, Teresa A. Pigott, et al

Article

Dopaminergic Agents and Stimulants as Antidepressant Augmentation Strategies

August 1, 1998

Andrew A. Nierenberg, Darin Dougherty, Jerrold F. Rosenbaum

Article

Course and Treatment of Atypical Depression

February 1, 1998

Andrew A. Nierenberg, Jonathan E. Alpert, Joel Pava, et al

Article

Course and Treatment of Atypical Depression

February 1, 1998

Andrew A. Nierenberg, Jonathan E. Alpert, Joel Pava, et al

Partial Response, Nonresponse, and Relapse With Selective Serotonin Reuptake Inhibitors in Major Depression: A Survey of Current "Next-Step" Practices

Efficacy of Fluvoxamine in the Treatment of Major Depression With Comorbid Anxiety Disorders

Evolution of Remission as the New Standard in the Treatment of Depression

Evolution of Remission as the New Standard in the Treatment of Depression

Residual Symptoms in Depressed Patients Who Respond Acutely to Fluoxetine

The Texas Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder

Dopaminergic Agents and Stimulants as Antidepressant Augmentation Strategies

Course and Treatment of Atypical Depression

Course and Treatment of Atypical Depression

ELSEWHERE:

FOLLOW US:

Andrew A. Nierenberg, MD

Partial Response, Nonresponse, and Relapse With Selective Serotonin Reuptake Inhibitors in Major Depression: A Survey of Current "Next-Step" Practices

Efficacy of Fluvoxamine in the Treatment of Major Depression With Comorbid Anxiety Disorders

Evolution of Remission as the New Standard in the Treatment of Depression

Evolution of Remission as the New Standard in the Treatment of Depression

Residual Symptoms in Depressed Patients Who Respond Acutely to Fluoxetine

The Texas Medication Algorithm Project: Report of the Texas Consensus Conference Panel on Medication Treatment of Major Depressive Disorder

Dopaminergic Agents and Stimulants as Antidepressant Augmentation Strategies

Course and Treatment of Atypical Depression

Course and Treatment of Atypical Depression

Celebrating85 Years

Subscribe to readmore articles

Celebrating
85 Years

Subscribe to read
more articles